Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 106 | 190 | 262 | 589 | 494 |
| Receivables | 19 | 19 | 20 | 20 | 20 |
| TOTAL | $134 | $272 | $303 | $627 | $616 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 10 |
| Investments And Advances | 22,653 | 22,653 | 22,641 | 0 | 0 |
| Intangibles | 2,788 | 5,988 | 12,071 | 21,884 | 21,936 |
| Other Non-Current Assets | 1,102 | 1,102 | 1,102 | 1,102 | 1,102 |
| TOTAL | $26,543 | $29,743 | $35,814 | $22,986 | $23,048 |
| Total Assets | $26,677 | $30,015 | $36,117 | $23,613 | $23,663 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,088 | 10,675 | 11,257 | 8,994 | 4,653 |
| Accounts payable and accrued liabilities | 2,783 | 2,781 | 2,843 | 3,496 | 3,127 |
| Accrued Expenses | 2,625 | 2,625 | 2,625 | N/A | N/A |
| Other current liabilities | 704 | 423 | 198 | 2,965 | 3,402 |
| TOTAL | $19,200 | $16,505 | $16,923 | $15,455 | $11,182 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 256 | 2,202 | 418 | 1,126 | 469 |
| TOTAL | $N/A | $1,899 | $N/A | $N/A | $N/A |
| Total Liabilities | $19,200 | $18,403 | $16,923 | $15,455 | $11,182 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 408,292 | 399,684 | 392,872 | 378,630 | 91,259 |
| Common Shares | 4,073 | 3,992 | 3,919 | 3,753 | 906 |
| Retained earnings | -38,041 | -33,517 | -25,926 | -31,021 | -21,630 |
| Other shareholders' equity | -774 | -519 | -216 | 203 | 712 |
| TOTAL | $7,478 | $11,612 | $19,193 | $8,158 | $12,481 |
| Total Liabilities And Equity | $26,677 | $30,015 | $36,117 | $23,613 | $23,663 |